Abstract:
A process for preparing sponge-like macroporous gelatin microcarrier (I) comprises: (a) mixing gelatin soln. with forming agent, e.g., NaHCO3 or CaCO3 (The particle size is 20-30 μm or less), and adding the mixed soln of chloroform (II) and toluene (III) contg. 1-4% surfactant. (mixing ration of (II):(III) is 3:7); (b) agitating the mixt. at 300-1000rpm to form emulsion; (c) filtering it with 100 μm sieve and washing with D.W.; (d) cross-linking with glutaraldehyde, and drying to obtain the final product. The diameter of (I) is 150-500 μm and pore size of (I) is 20-50 μm.
Abstract:
PURPOSE: An arabinose metabolic pathway-introduced xylitol-producing strain and a method for producing xylitol using the same are provided to suppress arabitol generation. CONSTITUTION: A xylitol-producing strain(deposit number KCTC 11761BP) with suppressed arabitol generation is prepared by introducing a gene expression cassette containing an arabinoser metabolic pathway-associated gene into Candida sp. A method for procuring the strain comprises: a step of preparing a gene expression cassette having a terminator, a promoter, and a polynucleotide encoding L-arabinose isomerase; a step of preparing a gene having a promoter, a terminator, and a polynucleotide encoding L-ribrokinase; and a step of preparing a gene expression cassette having a promoter, a terminator, and a polynucleotide encoding L-ribrose-5-phosphate 4-epimerase.
Abstract:
PURPOSE: A kit comprising a labeled antibody, a fluorescence-labeled biosubstance, and a support is provided to analyze the content of specific carbohydrate. CONSTITUTION: A kit for glycoprotein analysis comprises: a fluorescence-labeled antibody which selectively binds to a protein region of the glycoprotein; a florescence-labeled biosubstance which selectively binds to carbohydrate region of the glycoprotein; and a support which binds to the glycoprotein. The biosubstance is lectin, antibody, aptamer, or peptides. The glycoprotein is purified glycoprotein or isolated from single cells. The support is coated with other antibodies which bind to the glycoprotein targeting the surface.
Abstract:
PURPOSE: A method for preparing xylitol of high yield in a medium containing glucose using a xylitol producing strain is provided to produce xylitol of high yield and high productivity without glucose suppression. CONSTITUTION: A gene construct contains a promoter containing a base of sequence number 1, a polynucleotide having a base of sequence number 7, and a terminator having a base of sequence number 2. The gene construct contains a promoter containing 1000bp or more base sequences, a polynucleotide having a base of sequence number 7, and a terminator having a base of sequence number 2. An expression vector contains one or more gene constructs. A method for producing a large amount of xylitols comprises: a step of culturing a xylotol-producing strain in a medium containing biomass hydrolysate and carbon source; a step of producing xylitol from the strain; and a step of isolating xylitol from the culture liquid.
Abstract:
본 발명은 자일리톨 탈수소효소의 발현이 억제된 자일리톨 생산균주를 이용하여 자일리톨을 고수율로 생산하는 방법에 관한 것이다. 본 발명의 자일리톨의 고수율 생산방법은 자일리톨 탈수소효소 유전자의 일부가 비특이적으로 결실, 치환 또는 부가되어 자일리톨 탈수소효소의 발현이 억제된 자일리톨 생산균주를 자일리톨의 전구체인 자일로스, 탄소원, 질소원 및 미량원소를 포함하는 배지에 접종하고, 배지에 함유된 자일로스가 전량 소모될 때까지 배양한 다음, 이로부터 자일리톨을 수득하는 단계를 포함한다. 본 발명의 자일리톨의 고수율 생산방법을 이용할 경우, 종래의 제조방법보다도 높은 수율로 자일리톨을 생산할 수 있었으므로, 자일리톨을 포함하는 각종 식품, 의약품 등의 제조에 널리 활용될 수 있을 것이다. 자일리톨, 자일로스, 자일리톨 탈수소효소, 자일리톨 생산균주
Abstract:
PURPOSE: A composition of treating diarrhea in mammals containing buforin II which is separated a Korean toad and has an antimicrobial effect against cause bacteria of diarrhea is provided. The composition exhibits high susceptibility against cause bacteria of diarrhea and kills cause bacteria by inhibition of intracellular physiological action of the diarrhea cause bacteria. CONSTITUTION: The composition for prevention and treatment of diarrhea contains 0.01 to 20% by weight of buforin II, based on the total weight of the composition. The composition is powder, a drug, a tablet or injectable formulation and can be also used as a vaccine preparation, a feed additive or a beverage additive. Daily dose of between about 400μg to 4mg/day is sufficient to treat diarrhea in mammals.
Abstract:
PURPOSE: A composition of treating mastitis in mammals containing buforin II having an antimicrobial effect against microorganism causing mastitis of a lactating cow is provided. The composition is excellent in stability as well as mastitis treating effect, inhibits generation of antibiotic resistant strains of bacteria and repels cause bacteria. CONSTITUTION: The mastitis treating composition contains 0.01 to 20% by weight of buforin II and additionally an excipient, based on the total weight of the composition. The excipient is one or more selected from the group consisting of an aqueous ointment base material, oily ointment base material, olive oil and white bee'wax. Daily dosages of between about 8 and 80mg/day are sufficient to treat mastitis in mammals.
Abstract:
본 발명은 자일리톨 탈수소효소(xylitol dehydrogenase, XDH )가 제거된 기존의 변이주에서 자일룰로스 키나아제(xylulose kinase, XK )를 추가적으로 제거한 생산균주 및 이를 이용하여 반복적인 발효공정에도 높은 수율을 나타내는 자일리톨 생산방법에 관한 것이다. 구체적으로, 자일룰로스 키나아제 유전자의 활성이 제거된 균주를 선별하였으며, 선별된 균주의 반복적인 발효실험을 통해 균주의 발효 생리학적 특성을 분석하여 공정을 최적화하고, 반복적인 발효공정에도 높은 수율을 유지할 수 있는 균주 및 공정을 확립함으로써, 본 발명의 자일리톨 생산균주 및 생산방법이 고수율, 고생산성으로 자일리톨을 생산하는데 유용하게 사용될 것이다.
Abstract:
PURPOSE: A method for preparing xylitol at a high yield by the constitutive expression of xylose reductase is provided to massively produce xylitol. CONSTITUTION: A gene construct comprises: a promoter having a base sequence of sequence number 1; a polynucleotide having a base sequence of sequence number 7; and a terminator having a base sequence of sequence number 2. A strain which produces xylitol is cultured in a medium containing biomass hydrolysate and carbon source. The biomass hydrolysate is selected from the group consisting of corncob hydrolysate, sugar cane cob hydrolysate, coconut by-product, and Betula platyphylla var. japonica (Miquel) Hara hydrolysate.
Abstract:
PURPOSE: A method for diagnosing colon cancer is provided to detect alpha 1-3/4 fucose level using AAL lectin and to enable simple diagnose of colon cancer. CONSTITUTION: A method for diagnosing colon cancer comprises: a step of pretreating alpha 1-6 fucosidase to test sample-derived blood; a step of treating the blood to an anti-beta-haptoglobin antibody-conjugated solid substrate and washing; a step of treating with AAL(Aleuria aurantia agglutinin) lectin on the substrate and washing; and a step of determining colon cancer in case that the AAL lectin attachment level is increased comparing the level of healthy person.